Vice President Thomas Hutton sold 4,827 shares of Chemed Corp (NYSE:CHE) on August 6, 2024, according to a recent SEC filing. Following this transaction, the insider now owns 32,765 shares of the company’s stock.
Chemed Corp operates two main subsidiaries: VITAS Healthcare, a provider of end-of-life care, and Roto-Rooter, a plumbing and water purification service. This diversification allows Chemed Corp to serve a wide range of needs in the healthcare and service sectors.
On the day of the sale, Chemed Corp’s share price was $576.32, giving the company a market capitalization of approximately $8.679 billion. The price-to-earnings ratio was 29.35, above the industry median of 23.75 and the company’s historical median.
Chemed Corp’s GF Value is calculated at $564.71, which means the stock is fairly valued with a Price to GF Value ratio of 1.02. The GF Value is derived from historical trading multiples, an adjustment factor based on past performance, and future business projections.
There were no insider purchases at Chemed Corp over the past year, but there were 19 insider sales, highlighting a trend of insider selling. Thomas Hutton’s recent transaction is part of this ongoing pattern, as he sold a total of 4,827 shares and made no purchases over the same period.
These insider activities and current valuation metrics provide investors with an overview of Chemed Corp’s stock performance and insider sentiment.
This article created by GuruFocus is intended to provide general insights and does not constitute tailored financial advice. Our commentary is based on historical data and analyst forecasts, uses an unbiased methodology and is not intended to serve as specific investment advice. It does not contain a recommendation to buy or sell any stock and does not take into account any individual investment objectives or financial circumstances. Our goal is to provide long-term, fundamental, data-driven analysis. Note that our analysis may not include the most recent, price-sensitive company announcements or qualitative information. GuruFocus does not hold a position in any stocks mentioned here.
This article first appeared on GuruFocus.
